Endocrinology — MCQs

A 33-year-old man complains of a tingling sensation in his hands for several months, which occasionally awakens him during sleep. The patient has noticed he has gained weight and no longer wears his wedding ring as it has become too tight. Upon examination, the patient is noted to be sweating while speaking and has a prominent jaw, furrowed tongue, and large hands. His blood pressure is 142/91 mmHg. What is the most appropriate investigation?

Q429Medium

A 45-year-old male with a known history of diabetes mellitus has an HbA1c of 9.4% despite strict glycemic control. Which of the following complications can be reversed?

Q430Easy

Which of the following most closely represents the lowest detection limit for third-generation TSH assays?

Endocrinology Indian Medical PG Practice Questions and MCQs

Question 421: A 29-year-old person, known diabetic on oral hypoglycemic agents for 3 years, has lost weight and never had diabetic ketoacidosis. His grandfather is diabetic, but his father is not. Which of the following is the likely diagnosis?

A. Maturity Onset Diabetes of the Young (MODY)
B. Diabetes Mellitus type I
C. Diabetes Mellitus type II (Correct Answer)
D. Pancreatic diabetes

Explanation: ### Explanation **Correct Answer: C. Diabetes Mellitus type II** The clinical presentation points toward **Type 2 Diabetes Mellitus (T2DM)** based on the following factors: 1. **Treatment History:** The patient has been successfully managed on oral hypoglycemic agents (OHAs) for 3 years. Type 1 DM patients are insulin-dependent from the start and rarely respond to OHAs for such a duration. 2. **Absence of DKA:** The lack of Diabetic Ketoacidosis (DKA) despite a 3-year history suggests significant residual insulin secretion, which is characteristic of T2DM rather than Type 1. 3. **Inheritance Pattern:** The family history (Grandfather affected, Father skipped) suggests a **multifactorial or polygenic inheritance**, which is typical for T2DM. While weight loss is often associated with Type 1, it can occur in Type 2 due to osmotic diuresis and glucose loss when glycemic control is poor. **Why other options are incorrect:** * **A. MODY:** Maturity Onset Diabetes of the Young typically presents with **autosomal dominant inheritance**, meaning it usually affects every generation (Grandfather → Father → Son). The "skipped generation" here makes MODY less likely. * **B. Diabetes Mellitus type I:** These patients are usually lean, prone to DKA, and require insulin immediately. A 3-year history of OHA use effectively rules this out. * **D. Pancreatic Diabetes:** This usually follows chronic pancreatitis and is characterized by a history of abdominal pain, steatorrhea, and pancreatic calcifications on imaging (none of which are mentioned). **NEET-PG High-Yield Pearls:** * **MODY 3 (HNF-1α)** is the most common subtype globally; **MODY 2 (Glucokinase)** is the most common in some European cohorts. * **T2DM** has a stronger genetic predisposition than T1DM. * **LADA (Latent Autoimmune Diabetes in Adults)**: Often misdiagnosed as T2DM, but these patients are usually lean and eventually become insulin-dependent within months to a few years.

Question 422: Conn's syndrome is characterized by:

A. Hyperinsulinism
B. Hyperthyroidism
C. Hypoadrenalism
D. Hyperaldosteronism (Correct Answer)

Explanation: **Explanation:** **Conn’s Syndrome** (Primary Hyperaldosteronism) is a condition characterized by the autonomous overproduction of aldosterone from the adrenal cortex, most commonly due to an aldosterone-secreting adrenal adenoma (60-70%) or bilateral adrenal hyperplasia. **Why Option D is Correct:** Aldosterone acts on the distal convoluted tubules and collecting ducts of the kidney to promote **sodium and water reabsorption** and **potassium/hydrogen ion excretion**. Consequently, Conn’s syndrome presents with the classic triad of **Hypertension** (due to volume expansion), **Hypokalemia** (leading to muscle weakness), and **Metabolic Alkalosis**. **Why Other Options are Incorrect:** * **A. Hyperinsulinism:** This refers to excessive insulin levels, typically seen in Insulinomas or Nesidioblastosis, leading to hypoglycemia. * **B. Hyperthyroidism:** This involves excessive thyroid hormone (T3/T4) production (e.g., Graves' disease), presenting with tachycardia, weight loss, and heat intolerance. * **C. Hypoadrenalism:** This is the opposite of Conn’s; conditions like Addison’s disease involve a deficiency of adrenal hormones (cortisol and aldosterone), leading to hypotension and hyperkalemia. **High-Yield Clinical Pearls for NEET-PG:** * **Screening Test:** Plasma Aldosterone Concentration (PAC) to Plasma Renin Activity (PRA) ratio. A **PAC:PRA ratio > 20-30** is highly suggestive. * **Confirmatory Test:** Saline infusion test (failure to suppress aldosterone) or Oral Salt Loading test. * **Drug of Choice:** **Spironolactone** (Aldosterone antagonist) is used for bilateral hyperplasia or as preoperative medical management. * **Key Association:** Conn’s syndrome is a secondary cause of hypertension where **plasma renin levels are characteristically low** (suppressed by volume expansion).

Question 423: A 63-year-old woman with well-controlled Type II diabetes mellitus presents with peripheral neuropathy in the feet and non-proliferative retinopathy. Urinalysis is positive for proteinuria. Which of the following treatments is most likely to attenuate the course of renal disease?

A. Calcium channel blockers
B. ACE inhibitors (Correct Answer)
C. Hepatic hydroxymethylglutaryl-coenzyme A (HMG-CoA) inhibitors
D. Dietary carbohydrate restriction

Explanation: ### Explanation The patient presents with classic microvascular complications of Type II Diabetes Mellitus (neuropathy, retinopathy, and proteinuria), indicating **Diabetic Nephropathy (DN)** [1]. **1. Why ACE Inhibitors are correct:** ACE inhibitors (and ARBs) are the gold standard for managing diabetic nephropathy. The underlying mechanism involves the inhibition of Angiotensin II, which normally causes **vasoconstriction of the efferent arteriole**. By dilating the efferent arteriole, ACE inhibitors **reduce intraglomerular capillary pressure**, thereby decreasing the glomerular filtration rate (GFR) to a sustainable level and significantly reducing albuminuria [2]. This "renoprotective" effect slows the progression to End-Stage Renal Disease (ESRD) independently of their blood pressure-lowering effects [2]. **2. Why the other options are incorrect:** * **A. Calcium channel blockers:** While effective for hypertension, non-dihydropyridines (like Verapamil) have only modest antiproteinuric effects compared to ACE inhibitors. Dihydropyridines (like Amlodipine) may actually increase intraglomerular pressure if used as monotherapy. * **C. HMG-CoA inhibitors (Statins):** These are essential for cardiovascular risk reduction in diabetics but do not directly attenuate the progression of renal parenchymal damage or proteinuria. * **D. Dietary carbohydrate restriction:** While crucial for glycemic control (HbA1c management), it does not specifically target the hemodynamic changes in the kidney responsible for the progression of established proteinuria [3]. **Clinical Pearls for NEET-PG:** * **First sign of DN:** Microalbuminuria (30–300 mg/day) [1]. * **Pathological hallmark:** Kimmelstiel-Wilson (KW) nodules (nodular glomerulosclerosis) [1]. * **Management Tip:** Always monitor serum potassium and creatinine within 1–2 weeks of starting an ACE inhibitor, as they can cause hyperkalemia or a functional (but usually acceptable) rise in creatinine [2]. * **Combination Therapy:** Never combine ACE inhibitors and ARBs due to the high risk of hyperkalemia and acute kidney injury.

Question 424: What is the most common presentation of sick euthyoid state?

A. Low T3 with normal T4 (Correct Answer)
B. Low T3 with low T4
C. Low T3 with high T4
D. High T3 with high T4

Explanation: **Explanation:** **Sick Euthyroid Syndrome (SES)**, also known as Non-Thyroidal Illness Syndrome (NTIS), refers to alterations in thyroid function tests seen in patients with severe systemic illness (e.g., sepsis, trauma, or starvation) in the absence of pre-existing thyroid disease. **Why Option A is Correct:** The most common and earliest finding in SES is a **Low T3 level with a normal T4 and normal TSH**. This occurs due to the inhibition of the enzyme **5’-deiodinase**, which normally converts T4 (pro-hormone) to T3 (active hormone) in peripheral tissues [1]. Instead, T4 is diverted to form **Reverse T3 (rT3)**, which is metabolically inactive. **Analysis of Incorrect Options:** * **Option B (Low T3, Low T4):** This is seen in **severe or prolonged illness**. As the severity of the systemic disease increases, T4 levels also drop (Low T4 syndrome), which is a poor prognostic indicator. However, it is not the *most common* initial presentation. * **Option C & D:** These patterns are not characteristic of SES. High T4 is rarely seen unless there is an inhibition of T4 uptake by hepatocytes (transiently in acute illness), and high T3 is never a feature of sick euthyroid state. **NEET-PG High-Yield Pearls:** 1. **Hallmark:** Low T3, High Reverse T3 (rT3), and Normal TSH. 2. **TSH Paradox:** Although T3 is low, TSH remains normal (or mildly low) because the pituitary-thyroid axis is "reset" during stress. 3. **Management:** Do **NOT** treat with thyroxine. The condition resolves spontaneously once the underlying systemic illness is treated. 4. **Prognosis:** A very low T4 level in a critically ill patient is associated with a high mortality rate.

Question 425: Insulin sensitivity increases with the following treatments except:

A. Metformin
B. Acarbose
C. Exercise
D. Fasting (Correct Answer)

Explanation: ### Explanation The core concept tested here is the physiological adaptation to starvation versus the pharmacological/lifestyle management of insulin resistance. **Why Fasting is the Correct Answer:** During **fasting** (prolonged starvation), the body enters a "glucose-sparing" mode to preserve blood sugar for the brain. This leads to a state of **physiologic insulin resistance** [4]. As insulin levels drop, the body increases lipolysis and fatty acid oxidation [4]. Elevated free fatty acids (FFAs) inhibit glucose uptake in skeletal muscle (the **Randle Cycle**), effectively decreasing insulin sensitivity to ensure peripheral tissues utilize ketones and fats instead of glucose. **Analysis of Incorrect Options:** * **Metformin:** This is an insulin sensitizer. Its primary mechanism involves activating **AMPK**, which inhibits hepatic gluconeogenesis and improves peripheral glucose uptake in muscles, thereby increasing insulin sensitivity [1]. * **Acarbose:** An alpha-glucosidase inhibitor that delays carbohydrate absorption. By reducing postprandial glucose spikes, it reduces the demand on insulin and has been shown to indirectly improve insulin sensitivity by reducing "glucotoxicity." * **Exercise:** Physical activity is one of the most potent stimulators of insulin sensitivity [2]. It induces the translocation of **GLUT-4 receptors** to the cell membrane of skeletal muscles via insulin-independent pathways (AMPK activation), significantly enhancing glucose uptake. **High-Yield Clinical Pearls for NEET-PG:** * **Thiazolidinediones (Pioglitazone):** These are the most potent insulin sensitizers; they act via the **PPAR-̳ receptor** [1], [3]. * **The Randle Cycle (Glucose-Fatty Acid Cycle):** Explains why high levels of plasma fatty acids (seen in fasting and obesity) lead to insulin resistance. * **Metformin & Weight:** Unlike sulfonylureas or insulin, Metformin is weight-neutral or leads to weight loss, further aiding insulin sensitivity. * **Incretin Effect:** Oral glucose causes a higher insulin release than IV glucose due to GLP-1 and GIP; this effect is often diminished in Type 2 Diabetes [3].

Question 426: For the following causes of sexual dysfunction, select the most likely clinical feature.

A. loss of sexual desire
B. failure of erection with absent nocturnal penile tumescence (NPT)
C. absence of emission
D. absence of orgasm with normal libido and erectile function (Correct Answer)

Explanation: **Explanation:** Sexual dysfunction in males is categorized into disorders of desire, erection, emission, and orgasm. Understanding the physiological sequence is key to differentiating these causes. [1] **1. Why Option D is Correct:** The question focuses on **Anorgasmia** (inhibited female/male orgasm). In this condition, the patient maintains a normal **libido** (desire) and normal **erectile function** (parasympathetic response), but is unable to reach the climax or threshold required for orgasm. This is often associated with psychological factors, chronic opioid use, or the use of Selective Serotonin Reuptake Inhibitors (SSRIs). [1] **2. Analysis of Incorrect Options:** * **Option A (Loss of sexual desire):** This refers to **Hypoactive Sexual Desire Disorder (HSDD)**. It is primarily driven by hormonal deficiencies (e.g., Hypogonadism/Low Testosterone) or psychological issues like depression. [1] * **Option B (Failure of erection with absent NPT):** The absence of **Nocturnal Penile Tumescence (NPT)** is a hallmark of **Organic Erectile Dysfunction** (e.g., vascular disease, diabetes, or neurogenic causes). If NPT were present, the cause would likely be psychogenic. [2] * **Option C (Absence of emission):** Emission is the movement of semen into the prostatic urethra (mediated by sympathetic fibers T10-L2). Absence of emission occurs in **Retrograde Ejaculation** (common post-TURP surgery) or sympathetic nerve damage (e.g., diabetic neuropathy). **Clinical Pearls for NEET-PG:** * **Erection** is Parasympathetic (**P**oint); **Ejaculation** is Sympathetic (**S**hoot). * **Drug-induced dysfunction:** SSRIs are the most common pharmacological cause of delayed ejaculation and anorgasmia. * **Sildenafil (PDE-5 Inhibitor):** Works by increasing cGMP levels, but requires intact libido/sexual stimulation to be effective. * **Prolactinoma:** Always check Prolactin levels in patients with loss of libido and erectile dysfunction. [2]

Question 427: What is the confirmatory test for Cushing's disease?

A. High-dose dexamethasone suppression test
B. 24-hour urine free cortisol
C. Overnight dexamethasone suppression test
D. Bilateral inferior petrosal sinus sampling (Correct Answer)

Explanation: ### Explanation The diagnostic approach to Cushing’s syndrome follows a strict hierarchy: first, confirm hypercortisolism; second, determine if it is ACTH-dependent; and third, localize the source [1]. **Why Bilateral Inferior Petrosal Sinus Sampling (BIPSS) is correct:** BIPSS is the **gold standard** for differentiating between a pituitary source (Cushing’s Disease) and an ectopic source of ACTH. It involves measuring ACTH levels in the venous drainage of the pituitary gland compared to peripheral blood. A central-to-peripheral ACTH ratio of **≥2:1 (basal)** or **≥3:1 (after CRH stimulation)** confirms Cushing’s disease with high sensitivity and specificity. It is typically performed when biochemical tests suggest a pituitary source but MRI is inconclusive or negative. **Analysis of Incorrect Options:** * **B & C (24-hour Urine Free Cortisol & Overnight DST):** These are **screening tests** used to establish the presence of hypercortisolism (Cushing’s Syndrome) [1]. They do not differentiate the underlying cause (pituitary vs. adrenal vs. ectopic). * **A (High-dose Dexamethasone Suppression Test - HDDST):** Historically used to distinguish Cushing’s disease from ectopic ACTH, HDDST is no longer considered the "confirmatory" test due to its lower accuracy compared to BIPSS and modern imaging [1]. **NEET-PG High-Yield Pearls:** * **Screening:** Best initial test is either Late-night salivary cortisol, 24-hr urinary free cortisol, or Low-dose DST [1]. * **Localization:** If ACTH is high (>20 pg/mL), it is ACTH-dependent [2]. Perform MRI Brain. * **The "Rule of 6mm":** If MRI shows a pituitary adenoma **>6 mm**, Cushing’s disease is confirmed. If <6 mm or MRI is normal, **BIPSS** is the next step to confirm the source. * **Most common cause** of endogenous Cushing’s syndrome: Cushing’s Disease (Pituitary adenoma).

Question 428: A 33-year-old man complains of a tingling sensation in his hands for several months, which occasionally awakens him during sleep. The patient has noticed he has gained weight and no longer wears his wedding ring as it has become too tight. Upon examination, the patient is noted to be sweating while speaking and has a prominent jaw, furrowed tongue, and large hands. His blood pressure is 142/91 mmHg. What is the most appropriate investigation?

A. MRI scan of the pituitary
B. Glucose tolerance test (Correct Answer)
C. Growth hormone levels
D. Serum prolactin levels

Explanation: ### Explanation The clinical presentation of weight gain, tightening of rings (soft tissue swelling), prominent jaw (prognathism), furrowed tongue (macroglossia), and excessive sweating is classic for **Acromegaly**, caused by excessive Growth Hormone (GH) secretion. The tingling in the hands suggests **Carpal Tunnel Syndrome**, a common complication of acromegaly due to soft tissue overgrowth compressing the median nerve. #### Why Option B is Correct The **Oral Glucose Tolerance Test (OGTT) with GH measurement** is the **gold standard confirmatory test** for acromegaly [1]. In a healthy individual, a high glucose load (75g) suppresses GH levels to <1 ng/mL. In acromegaly, there is a failure to suppress GH, or even a paradoxical rise, confirming autonomous secretion [1]. While Serum IGF-1 is the best *screening* test, OGTT is the definitive biochemical investigation [1]. #### Why Other Options are Incorrect * **A. MRI scan of the pituitary:** This is the investigation of choice for *localization* of the tumor (usually a macroadenoma) [1]. However, biochemical confirmation (OGTT) must always precede imaging to avoid incidentaloma findings [2]. * **C. Growth hormone levels:** A single random GH measurement is unreliable because GH is secreted in pulsatile bursts and has a short half-life. * **D. Serum prolactin levels:** While 25-30% of GH-secreting tumors also secrete prolactin (mammosomatotrophs), it is not the diagnostic test for acromegaly [1]. #### NEET-PG High-Yield Pearls * **Best Screening Test:** Serum IGF-1 (reflects GH activity over 24 hours) [1]. * **Best Confirmatory Test:** OGTT (GH suppression test) [1]. * **Most Common Cause of Death:** Cardiovascular disease (Cardiomyopathy/Hypertension). * **Associated Cancer Risk:** Increased risk of **Colonic Polyps and Adenocarcinoma**; screening colonoscopy is recommended [1]. * **Visual Defect:** Bitemporal hemianopia (due to optic chiasm compression) [2].

Question 429: A 45-year-old male with a known history of diabetes mellitus has an HbA1c of 9.4% despite strict glycemic control. Which of the following complications can be reversed?

A. Retinopathy
B. Neuropathy
C. Nephropathy
D. None of the above (Correct Answer)

Explanation: ### Explanation The correct answer is **D. None of the above.** This question tests the understanding of the **"Point of No Return"** in diabetic microvascular complications. Once structural damage occurs due to chronic hyperglycemia, these complications are generally considered **irreversible** or, at best, can only be stabilized to prevent further progression [1]. **Why "None of the above" is correct:** The underlying pathophysiology involves advanced glycation end-products (AGEs), oxidative stress, and structural changes like basement membrane thickening and capillary loss [3]. While strict glycemic control (as evidenced by the patient’s high HbA1c of 9.4% needing intervention) can **slow the progression** of these diseases, it cannot reverse the established anatomical damage [1]. **Analysis of Incorrect Options:** * **Retinopathy (A):** Diabetic retinopathy involves microaneurysms, hemorrhages, and neovascularization. While laser photocoagulation or VEGF inhibitors can treat complications by reducing macular oedema or neovascularization, they do not "reverse" the underlying retinal damage to a pre-diabetic state [2]. * **Neuropathy (B):** Diabetic peripheral neuropathy involves axonal degeneration and segmental demyelination. While symptoms (like pain) can be managed and progression slowed, the loss of nerve fibers is permanent. * **Nephropathy (C):** Once a patient reaches the stage of persistent macroalbuminuria or histological changes like Kimmelstiel-Wilson nodules, the damage is permanent [3]. Only very early "hyperfiltration" or microalbuminuria may show regression with ACE inhibitors/ARBs, but established nephropathy is irreversible. **Clinical Pearls for NEET-PG:** * **Metabolic Memory (Legacy Effect):** Early intensive glycemic control provides long-term benefits even if control worsens later (proven by DCCT/EDIC and UKPDS trials) [1]. * **Reversible Diabetic Changes:** Only functional changes like **sorbitol-induced osmotic swelling** of the lens (causing blurred vision) or **early hyperfiltration** in the kidneys are truly reversible. * **Screening:** Annual screening for microalbuminuria and fundus examination is vital because prevention is the only "cure."

Question 430: Which of the following most closely represents the lowest detection limit for third-generation TSH assays?

A. 0.4 mIU/L
B. 0.04 mIU/L (Correct Answer)
C. 0.004 mIU/L
D. 0.0004 mIU/L

Explanation: **Explanation:** The evolution of TSH assays is defined by their **functional sensitivity**, which is the lowest concentration of TSH that can be measured with a coefficient of variation (CV) of less than 20% [1]. This sensitivity determines the assay's ability to distinguish between suppressed and subnormal TSH levels [1]. * **Correct Answer (B):** Third-generation TSH assays have a functional sensitivity of **0.01 to 0.02 mIU/L**, though they are broadly categorized by a detection limit of **0.01–0.05 mIU/L**. Therefore, **0.04 mIU/L** is the most accurate representation among the choices. These assays are the current clinical standard, allowing clinicians to distinguish between mild (subclinical) hyperthyroidism and profound TSH suppression seen in overt Graves' disease [1]. **Analysis of Incorrect Options:** * **Option A (0.4 mIU/L):** This represents the lower limit of the **normal reference range** for TSH in healthy adults, not the detection limit of the assay itself. * **Option C (0.004 mIU/L):** This corresponds to **fourth-generation assays**, which have a sensitivity of <0.005 mIU/L. While highly sensitive, they are primarily used in research settings and are not the standard "third-generation" assays used in routine practice. * **Option D (0.0004 mIU/L):** This value is beyond the capability of current clinical diagnostic technology. **High-Yield Clinical Pearls for NEET-PG:** * **Generations Rule of 10:** Each generation is roughly 10 times more sensitive than the previous one: * 1st Gen: 1.0 mIU/L * 2nd Gen: 0.1 mIU/L * 3rd Gen: 0.01 mIU/L * **Clinical Utility:** Third-generation assays are essential for monitoring **Levothyroxine suppression therapy** in thyroid cancer patients and for diagnosing **Subclinical Hyperthyroidism** (Low TSH with normal T3/T4) [1]. * **Best Initial Test:** Serum TSH is the single most sensitive and specific test for screening thyroid dysfunction [1].

Practice by Chapter

Diabetes Mellitus

Practice Questions

Thyroid Disorders

Practice Questions

Adrenal Gland Disorders

Practice Questions

Pituitary Disorders

Practice Questions

Calcium and Bone Metabolism

Practice Questions

Reproductive Endocrinology

Practice Questions

Lipid Disorders

Practice Questions

Endocrine Hypertension

Practice Questions

Multiple Endocrine Neoplasia

Practice Questions

Obesity and Metabolic Syndrome

Practice Questions

Neuroendocrine Tumors

Practice Questions

Endocrine Emergencies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free